Table 4.
Pretreatment and posttreatment assessment for PHQ-9, GAD-7, and EQ5D5L.
| Variable | T0, mean (SD) | T1, mean (SD) | t (df)/Z | P value | Effect size (g) | 95% CI |
| PHQ-9a | 9.46 (3.59) | 5.54 (3.21) | 6.75 (49)b | <.001 | 1.15 | 2.75-5.1 |
| GAD-7c | 7.54 (3.8) | 4.2 (2.65) | –4.22d | <.001 | 1.02 | 2.06-4.61 |
| EQ5D5Le | 0.83 (0.10) | 0.88 (0.10) | –2.66d | .008 | 0.50 |
|
aPHQ-9: 9-item Patient Health Questionnaire.
bPaired sample test.
cGAD-7: 7-item Generalized Anxiety Disorder.
dWilcoxon signed-rank test.
eEQ5D5L: Euro Quality of Life 5 Dimension-5 Level Scale.